127 related articles for article (PubMed ID: 9698216)
1. Effects of the alkylating agent EEDQ on regulatory G proteins and recovery of agonist and antagonist alpha2-adrenoceptor binding sites in rat brain.
Ribas C; Miralles A; Escribá PV; García-Sevilla JA
Eur J Pharmacol; 1998 Jun; 351(1):145-54. PubMed ID: 9698216
[TBL] [Abstract][Full Text] [Related]
2. Chronic clorgyline induces selective down-regulation of alpha2-adrenoceptor agonist binding sites in rat brain.
Miralles A; Ribas C; Escribá PV; García-Sevilla JA
Pharmacol Toxicol; 2000 Dec; 87(6):269-75. PubMed ID: 11140825
[TBL] [Abstract][Full Text] [Related]
3. Acceleration by chronic treatment with clorgyline of the turnover of brain alpha 2-adrenoceptors in normotensive but not in spontaneously hypertensive rats.
Ribas C; Miralles A; García-Sevilla JA
Br J Pharmacol; 1993 Sep; 110(1):99-106. PubMed ID: 8106111
[TBL] [Abstract][Full Text] [Related]
4. Recovery of alpha 2-adrenoceptor binding and function after irreversible inactivation by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ).
Adler CH; Meller E; Goldstein M
Eur J Pharmacol; 1985 Oct; 116(1-2):175-8. PubMed ID: 2865161
[TBL] [Abstract][Full Text] [Related]
5. Covariation of alpha 2-adrenoceptor density and function following irreversible antagonism with EEDQ.
Durcan MJ; Morgan PF; Van Etten ML; Linnoila M
Br J Pharmacol; 1994 Jul; 112(3):855-60. PubMed ID: 7921612
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the interaction of agmatine and crude methanolic extracts of bovine lung and brain with alpha 2-adrenoceptor binding sites.
Pinthong D; Hussain JF; Kendall DA; Wilson VG
Br J Pharmacol; 1995 Jun; 115(4):689-95. PubMed ID: 7582492
[TBL] [Abstract][Full Text] [Related]
7. Differential effects of the alkylating agent N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline on brain alpha 2-adrenoceptors and I2-imidazoline sites in vitro and in vivo.
Miralles A; Ribas C; Olmos G; García-Sevilla JA
J Neurochem; 1993 Nov; 61(5):1602-10. PubMed ID: 8228980
[TBL] [Abstract][Full Text] [Related]
8. Brain alpha(2)-adrenoceptors in monoamine-depleted rats: increased receptor density, G coupling proteins, receptor turnover and receptor mRNA.
Ribas C; Miralles A; Busquets X; García-Sevilla JA
Br J Pharmacol; 2001 Apr; 132(7):1467-76. PubMed ID: 11264240
[TBL] [Abstract][Full Text] [Related]
9. Relationship between alpha 2-adrenergic receptor binding sites and the functional receptors inhibiting norepinephrine release in rat cerebral cortex.
Nasseri A; Minneman KP
Mol Pharmacol; 1987 Nov; 32(5):655-62. PubMed ID: 2891027
[TBL] [Abstract][Full Text] [Related]
10. Long term treatment with desipramine increases the turnover of alpha 2-adrenoceptors in the rat brain.
Barturen F; Garcia-Sevilla JA
Mol Pharmacol; 1992 Nov; 42(5):846-55. PubMed ID: 1359398
[TBL] [Abstract][Full Text] [Related]
11. A robust GTP-induced shift in alpha(2)-adrenoceptor agonist affinity in tissue sections from rat brain.
Bylund DB; Gerety ME; Happe HK; Murrin LC
J Neurosci Methods; 2001 Feb; 105(2):159-66. PubMed ID: 11275272
[TBL] [Abstract][Full Text] [Related]
12. Differential effects of N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ) on various 5-HT receptor binding sites in the rat brain.
Gozlan H; Laporte AM; Thibault S; Schechter LE; Bolaños F; Hamon M
Neuropharmacology; 1994; 33(3-4):423-31. PubMed ID: 7984280
[TBL] [Abstract][Full Text] [Related]
13. Differential sensitivity of [3H]7-OH-DPAT-labeled binding sites in rat brain to inactivation by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline.
Levant B
Brain Res; 1995 Nov; 698(1-2):146-54. PubMed ID: 8581473
[TBL] [Abstract][Full Text] [Related]
14. An in vivo procedure for the selective inactivation of rat brain cerebral cortical alpha-adrenoceptors using N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ).
Pilc A; Vetulani J; Nomura S; Enna SJ
Brain Res; 1989 Jul; 493(1):8-13. PubMed ID: 2570619
[TBL] [Abstract][Full Text] [Related]
15. Acute and chronic effects of cholinesterase inhibitors and pilocarpine on the density and sensitivity of central and peripheral alpha 2-adrenoceptors.
Olmos G; Miralles A; García-Sevilla JA; Giralt MT; Pineda J; Asier Garro M; Ugedo L; Menargues A; Obach R
Eur J Pharmacol; 1993 Jun; 236(3):467-76. PubMed ID: 8102972
[TBL] [Abstract][Full Text] [Related]
16. Species-selective binding of [3H]-idazoxan to alpha 2-adrenoceptors and non-adrenoceptor, imidazoline binding sites in the central nervous system.
Hussain JF; Kendall DA; Wilson VG
Br J Pharmacol; 1993 Jul; 109(3):831-7. PubMed ID: 8102937
[TBL] [Abstract][Full Text] [Related]
17. Inactivation of 5-HT1A and [3H]5-HT binding sites by N-ethoxycarbonyl-2-ethoxy-1, 2-dihydroquinoline (EEDQ) in rat brain.
Subhash MN; Srinivas BN; Vinod KY; Jagadeesh S
Neurochem Res; 1998 Oct; 23(10):1321-6. PubMed ID: 9804289
[TBL] [Abstract][Full Text] [Related]
18. Non-adrenergic sites for imidazolines are not directly involved in the alpha 2-adrenergic antilipolytic effect of UK 14304 in rat adipocytes.
Carpéné C; Galitzky J; Larrouy D; Langin D; Lafontan M
Biochem Pharmacol; 1990 Aug; 40(3):437-45. PubMed ID: 1974423
[TBL] [Abstract][Full Text] [Related]
19. N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ) administration for studies of 5-HT1A receptor binding site inactivation and turnover.
Keck BJ; Lakoski JM
Brain Res Brain Res Protoc; 1997 Oct; 1(4):364-70. PubMed ID: 9384817
[TBL] [Abstract][Full Text] [Related]
20. Central alpha 2-autoreceptors: agonist dissociation constants and recovery after irreversible inactivation.
Agneter E; Drobny H; Singer EA
Br J Pharmacol; 1993 Feb; 108(2):370-5. PubMed ID: 8095417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
